Insider Transactions in Q2 2024 at Fusion Pharmaceuticals Inc. (FUSN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2024
|
John Valliant Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
318,147
-100.0%
|
-
|
|
Jun 04
2024
|
Steven Gannon |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,400
-100.0%
|
-
|
|
Jun 04
2024
|
John J Crowley Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,410
-100.0%
|
-
|
|
Jun 04
2024
|
Mohit Rawat President & CBO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,699
-100.0%
|
-
|
|
Jun 04
2024
|
Christopher P Leamon Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,957
-100.0%
|
-
|
|
Jun 04
2024
|
Eric Burak Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
38,490
-100.0%
|
-
|